Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.060
-0.010 (-0.48%)
At close: Nov 7, 2025, 4:00 PM EST
2.100
+0.040 (1.94%)
After-hours: Nov 7, 2025, 7:20 PM EST
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $6.11 million as of November 7, 2025. Its market cap has increased by 9.89% in one year.
Market Cap
6.11M
Enterprise Value
4.33M
1-Year Change
9.89%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $6.11M, a decrease of -99.99%. That is a compound annual growth rate of -69.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 6.11M | -42.43% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | 18.67B | 21.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |